An examination of the interactions between the antinociceptive effects of morphine and various μ-opioids:: The role of intrinsic efficacy and stimulus intensity

被引:70
作者
Morgan, D [1 ]
Cook, CD [1 ]
Smith, MA [1 ]
Picker, MJ [1 ]
机构
[1] Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1097/00000539-199902000-00035
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We examined the effects of several opioids that vary in intrinsic efficacy at the mu-opioid receptor alone and in combination with morphine in a rat warm water tail withdrawal procedure using 50 degrees C and 52 degrees C water (i.e., low- and high-stimulus intensities). Morphine, levorphanol, dezocine, and buprenorphine produced dose-dependent increases in antinociception using both stimulus intensities. Butorphanol produced maximal levels of antinociception at the low, but not at the high, stimulus intensity, whereas nalbuphine failed to produce antinociception at either stimulus intensity. For cases in which butorphanol and nalbuphine failed to produce antinociception alone, these opioids dose-dependently antagonized the effects of morphine. When levorphanol, dezocine, and buprenorphine were combined with morphine, there was a dose-dependent enhancement of morphine's effects. Similar effects were obtained at the low-stimulus intensity when butorphanol was administered with morphine. In most cases, the effects of these combinations could be predicted by summating the effects of the drugs when administered alone. These results indicate that the level of antinociception produced by an opioid is dependent on the intrinsic efficacy of the drug and the stimulus intensity. Furthermore, the level of antinociception produced by the opioid, not necessarily the opioids' intrinsic efficacy, determines the type of interaction among opioids. Implications: Compared with high-efficacy opioids, lower efficacy opioids produce lower levels of pain relief, especially in situations of moderate to severe pain. When opioids are given in combination, the effects can only be predicted on the basis of the antinociception obtained when the drugs are administered alone.
引用
收藏
页码:407 / 413
页数:7
相关论文
共 25 条
[1]  
ADAMS JU, 1990, J PHARMACOL EXP THER, V255, P1027
[2]   SIDE-EFFECTS OF NALBUPHINE WHILE REVERSING OPIOID-INDUCED RESPIRATORY DEPRESSION - REPORT OF 4 CASES [J].
BLAISE, GA ;
NUGENT, M ;
MCMICHAN, JC ;
DURANT, PAC .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1990, 37 (07) :794-797
[3]  
BUTELMAN ER, 1995, J PHARMACOL EXP THER, V272, P845
[4]  
FRANCE CP, 1990, J PHARMACOL EXP THER, V254, P626
[5]   ADVERSE-EFFECTS OF EXTRADURAL AND INTRATHECAL OPIATES - REPORT OF A NATIONWIDE SURVEY IN SWEDEN [J].
GUSTAFSSON, LL ;
SCHILDT, B ;
JACOBSEN, K .
BRITISH JOURNAL OF ANAESTHESIA, 1982, 54 (05) :479-486
[6]  
HAMBROOK JM, 1976, OPIATES ENDOGENOUS O, P295
[7]  
Kenakin T., 1993, PHARM ANAL DRUG RECE
[8]  
MJANGER E, 1991, J PHARMACOL EXP THER, V258, P544
[9]   The μ opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the μ opioid receptor [J].
Morgan, D ;
Picker, MJ .
PSYCHOPHARMACOLOGY, 1998, 140 (01) :20-28
[10]  
Morgan D, 1996, BEHAV PHARMACOL, V7, P261